nedaplatin has been researched along with Sarcopenia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Haraga, J; Ida, N; Kiyotoki, T; Kusumoto, T; Masuyama, H; Nakamura, K; Nishida, T; Omichi, C; Saijo, M | 1 |
1 other study(ies) available for nedaplatin and Sarcopenia
| Article | Year |
|---|---|
Sarcopenia Is an Important Prognostic Factor in Patients With Cervical Cancer Undergoing Concurrent Chemoradiotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brachytherapy; Chemoradiotherapy; Cisplatin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Ifosfamide; Lymphatic Metastasis; Middle Aged; Organoplatinum Compounds; Retrospective Studies; Sarcopenia; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2018 |